Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
A promising new class of proteins for therapeutic purposes makes an entrance; small in size, with multiple low-affinity binding sites for their targets and many disulfide bonds, they are easy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results